Jacobsen Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $643K | Sell |
1,586
-41
| -3% | -$16.6K | 0.24% | 40 |
|
|
2025
Q1 | $810K | Buy |
1,627
+15
| +0.9% | +$7.46K | 0.35% | 29 |
|
|
2024
Q4 | $839K | Buy |
1,612
+7
| +0.4% | +$3.64K | 0.36% | 28 |
|
|
2024
Q3 | $993K | Sell |
1,605
-86
| -5% | -$53.2K | 0.42% | 23 |
|
|
2024
Q2 | $935K | Buy |
1,691
+26
| +2% | +$14.4K | 0.42% | 23 |
|
|
2024
Q1 | $968K | Buy |
1,665
+37
| +2% | +$21.5K | 0.45% | 21 |
|
|
2023
Q4 | $864K | Sell |
1,628
-102
| -6% | -$54.1K | 0.44% | 21 |
|
|
2023
Q3 | $876K | Buy |
1,730
+1
| +0.1% | +$506 | 0.48% | 22 |
|
|
2023
Q2 | $902K | Sell |
1,729
-480
| -22% | -$250K | 0.47% | 21 |
|
|
2023
Q1 | $1.27M | Sell |
2,209
-1,085
| -33% | -$625K | 0.68% | 17 |
|
|
2022
Q4 | $1.81M | Sell |
3,294
-367
| -10% | -$202K | 0.97% | 19 |
|
|
2022
Q3 | $1.86M | Sell |
3,661
-86
| -2% | -$43.6K | 1.06% | 17 |
|
|
2022
Q2 | $2.04M | Sell |
3,747
-605
| -14% | -$329K | 1.08% | 17 |
|
|
2022
Q1 | $2.57M | Buy |
4,352
+521
| +14% | +$308K | 1.18% | 17 |
|
|
2021
Q4 | $2.56M | Sell |
3,831
-104
| -3% | -$69.4K | 1.21% | 13 |
|
|
2021
Q3 | $2.25M | Buy |
3,935
+65
| +2% | +$37.1K | 1.13% | 15 |
|
|
2021
Q2 | $1.95M | Buy |
3,870
+107
| +3% | +$54K | 1% | 19 |
|
|
2021
Q1 | $1.72M | Sell |
3,763
-107
| -3% | -$48.8K | 0.95% | 19 |
|
|
2020
Q4 | $1.8M | Hold |
3,870
| – | – | 1.07% | 19 |
|
|
2020
Q3 | $1.71M | Sell |
3,870
-834
| -18% | -$368K | 1.19% | 18 |
|
|
2020
Q2 | $1.7M | Buy |
+4,704
| New | +$1.7M | 1.3% | 16 |
|
|
2019
Q4 | $1.48M | Sell |
4,568
-20
| -0.4% | -$6.5K | 1.48% | 14 |
|
|
2019
Q3 | $1.34M | Sell |
4,588
-10
| -0.2% | -$2.91K | 1.29% | 19 |
|
|
2019
Q2 | $1.35M | Buy |
+4,598
| New | +$1.35M | 1.35% | 17 |
|